Clinical Trials Logo

Anxiety Disorder Generalized clinical trials

View clinical trials related to Anxiety Disorder Generalized.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04598867 Not yet recruiting - Clinical trials for Anxiety Disorder Generalized

A Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder

Start date: December 2020
Phase: Phase 3
Study type: Interventional

This is a multicenter, randomized, double-blind, placebo- and active-controlled study to assess the efficacy and safety of CD-008-0045 in patients with generalized anxiety disorder (GAD). Each patient will participate in the study for the period of approximately 37 weeks: Screening and Run-in period: 1 week; Study Treatment period: 32 weeks; Follow-up period: 4 weeks.